Lymphoproliferative Disorders  >>  epirubicin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00556127: Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma

Completed
2
94
Europe
Rituximab, Epirubicin, Cyclophosphamide, Vincristine, Prednisone, Granulocyte-colony-stimulating factor, Mitoxantrone, Cytarabine ARA-C, Dexamethasone, Carmustine BCNU, Etoposide, Melphalan, Radiotherapy, PBSC reinfusion
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie
Diffuse Large B-Cell Lymphoma, POOR PROGNOSIS
 
09/06

Download Options